AJP - Cell Physiology, Vol 264, Issue 5 C1350-C1359, Copyright © 1993 by American Physiological Society

ARTICLES

Use of a PCR-based method to characterize protein kinase C isoform expression in cardiac cells

T. A. Kohout and T. B. Rogers
Department of Biological Chemistry, University of Maryland School of Medicine, Baltimore 21201.

Molecular cloning has identified at least nine unique isozymes of protein kinase C (PKC) designated alpha, beta I, beta II, gamma, delta, epsilon, zeta, and eta/L, with the recent addition of the theta-isoform. Previous attempts to characterize PKC isoform expression in heart have been limited by low levels of protein and perhaps by the presence of novel isoforms. Thus to critically examine the diversity of PKC expression in cardiac cells, we developed a reverse transcriptase-polymerase chain reaction (RT-PCR) approach that would amplify regions of the target cDNA of all the PKC isozymes in a single reaction. Degenerate oligonucleotide primers were designed to recognize sequences in the conserved regions of the PKC sequence motif: the cysteine-rich and the ATP-binding regions. Amplification of target PKC cDNA sequences resulted in PCR products with unique sizes and restriction digestion properties. The system was validated by identifying PCR products that correspond to all of the PKC isoform transcripts, except PKC-zeta, in a single reaction with cDNA derived from hippocampus. Cardiac cDNA was RT-PCR amplified, and the products were analyzed by a combination of restriction mapping and DNA sequencing that revealed the presence of only the alpha, delta, epsilon, and eta isoforms in adult rat cardiac myocytes and cultured neonatal ventricular myocytes. A unique nondegenerate primer pair was synthesized to recognize PKC-zeta cDNA. Results with these primers show that PKC-zeta is present in both cardiac myocyte preparations as well. The RT-PCR method developed here is an efficient approach that is broadly useful to examine PKC expression in many tissues, including the identification of potentially novel isoforms.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. Wright, I. S. Singh, J. D. Hasday, I. K. Farrance, G. Hall, A. S. Cross, and T. B. Rogers Endotoxin stress-response in cardiomyocytes: NF-kappa B activation and tumor necrosis factor-alpha expression Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H872 - H879. [Abstract] [Full Text] [PDF]

				G. W. Dorn II, N. M. Tepe, G. Wu, A. Yatani, and S. B. Liggett Mechanisms of Impaired beta -Adrenergic Receptor Signaling in Galpha q-Mediated Cardiac Hypertrophy and Ventricular Dysfunction Mol. Pharmacol., February 1, 2000; 57(2): 278 - 287. [Abstract] [Full Text]

				R. H. Strasser, G. Simonis, S. P. Schon, M. U. Braun, R. Ihl-Vahl, C. Weinbrenner, R. Marquetant, and W. Kubler Two Distinct Mechanisms Mediate a Differential Regulation of Protein Kinase C Isozymes in Acute and Prolonged Myocardial Ischemia Circ. Res., July 9, 1999; 85(1): 77 - 87. [Abstract] [Full Text] [PDF]

				C. J. Albert and D. A. Ford Protein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H642 - H650. [Abstract] [Full Text] [PDF]

				N. Bowling, R. A. Walsh, G. Song, T. Estridge, G. E. Sandusky, R. L. Fouts, K. Mintze, T. Pickard, R. Roden, M. R. Bristow, et al. Increased Protein Kinase C Activity and Expression of Ca2+-Sensitive Isoforms in the Failing Human Heart Circulation, January 26, 1999; 99(3): 384 - 391. [Abstract] [Full Text] [PDF]

				P. Sil, V. Kandaswamy, and S. Sen Increased Protein Kinase C Activity in Myotrophin-Induced Myocyte Growth Circ. Res., June 15, 1998; 82(11): 1173 - 1188. [Abstract] [Full Text] [PDF]

				H. Miyawaki and M. Ashraf Ca2+ as a Mediator of Ischemic Preconditioning Circ. Res., June 19, 1997; 80(6): 790 - 799. [Abstract] [Full Text]

				C. Ventura, G. Pintus, M. G. Fiori, F. Bennardini, G. Pinna, and L. Gaspa Opioid Peptide Gene Expression in the Primary Hereditary Cardiomyopathy of the Syrian Hamster. I. REGULATION OF PRODYNORPHIN GENE EXPRESSION BY NUCLEAR PROTEIN KINASE C J. Biol. Chem., March 7, 1997; 272(10): 6685 - 6692. [Abstract] [Full Text] [PDF]

				M. A. Sussman, S. F. Hamm-Alvarez, P. M. Vilalta, S. Welch, and L. Kedes Involvement of Phosphorylation in Doxorubicin-Mediated Myofibril Degeneration: An Immunofluorescence Microscopy Analysis Circ. Res., January 1, 1997; 80(1): 52 - 61. [Abstract] [Full Text]

				V. Rybin and S. F. Steinberg Thyroid Hormone Represses Protein Kinase C Isoform Expression and Activity in Rat Cardiac Myocytes Circ. Res., September 1, 1996; 79(3): 388 - 398. [Abstract] [Full Text]

				C. Vahlhaus, R. Schulz, H. Post, R. Onallah, and G. Heusch No Prevention of Ischemic Preconditioning by the Protein Kinase C Inhibitor Staurosporine in Swine Circ. Res., September 1, 1996; 79(3): 407 - 414. [Abstract] [Full Text]

				T. A. Kohout, J. J. O'Brian, S. T. Gaa, W. J. Lederer, and T. B. Rogers Novel Adenovirus Component System That Transfects Cultured Cardiac Cells With High Efficiency Circ. Res., June 1, 1996; 78(6): 971 - 977. [Abstract] [Full Text]

				P. Henry, S. Demolombe, M. Puceat, and D. Escande Adenosine A1 Stimulation Activates {delta}-Protein Kinase C in Rat Ventricular Myocytes Circ. Res., January 1, 1996; 78(1): 161 - 165. [Abstract] [Full Text]

				D. S. Damron, A. Darvish, L. Murphy, W. Sweet, C. S. Moravec, and M. Bond Arachidonic Acid–Dependent Phosphorylation of Troponin I and Myosin Light Chain 2 in Cardiac Myocytes Circ. Res., June 1, 1995; 76(6): 1011 - 1019. [Abstract] [Full Text]